Search

Your search keyword '"Fisher LM"' showing total 234 results

Search Constraints

Start Over You searched for: Author "Fisher LM" Remove constraint Author: "Fisher LM"
234 results on '"Fisher LM"'

Search Results

1. Can state law combat exclusionary zoning? Evidence from Massachusetts

2. Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex

3. A Prospective, Longitudinal Study of US Children Unable to Achieve Open-Set Speech Recognition Five Years after Cochlear Implantation

4. Molecular cloning and characterization of the human topoisomerase IIα and IIβ genes: evidence for isoform evolution through gene duplication 1Sequences described here have been submitted to the EMBL/GenBank databases under accession nos. AJ011721–AJ011732 and AJ011741–AJ011758. Part of this work was presented as a poster at the Fourth Conference on DNA Topoisomerases in Therapy, New York, 1992: J.-H. Sng, C.A. Austin, L.M. Fisher. Cloning the human topoisomerase IIα gene. Abstract P03. 1

6. Phase separation and isotope effect in the ferromagnetic insulating state of the Pr1-xCaxMnO3 system (0.2 <x <0.33)

14. Randomized double-blinded, placebo-controlled clinical trial of famciclovir for reduction of Ménière's disease symptoms.

16. DNase I hypersensitive sites in the chromatin of human μ immunoglobulin heavy-chain genes

19. Genetic mutation as a cause of male infertility in two brothers.

21. Experimental localization of metal-binding sites reveals the role of metal ions in type II DNA topoisomerases.

22. Changes in soluble LDL receptor and lipoprotein fractions in response to diet in the DIETFITS weight loss study.

23. Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria.

24. Prospective Evaluation of a Smartphone Otoscope for Home Tympanostomy Tube Surveillance: A Pilot Study.

25. Prevalence of Tinnitus and Associated Factors Among Asian Americans: Results From a National Sample.

26. Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.

27. Initiation, dropout, and outcome from evidence-based psychotherapies in a VA PTSD outpatient clinic.

28. Assessing the Benefit-Risk Profile for Pediatric Implantable Auditory Prostheses.

29. Speech and Communicative Participation in Patients With Facial Paralysis.

30. Trapping of the transport-segment DNA by the ATPase domains of a type II topoisomerase.

31. Early Communication Development of Children with Auditory Brainstem Implants.

32. Prevalence of Hearing Loss and Hearing Care Use Among Asian Americans: A Nationally Representative Sample.

33. Abnormal Cochleovestibular Anatomy and Hearing Outcomes: Pediatric Patients with a Questionable Cochleovestibular Nerve Status May Benefit from Cochlear Implantation and/or Hearing Aids.

34. Age-related histologic and biochemical changes in auricular and septal cartilage.

36. Initial Results of a Safety and Feasibility Study of Auditory Brainstem Implantation in Congenitally Deaf Children.

37. Exploring the active site of the Streptococcus pneumoniae topoisomerase IV-DNA cleavage complex with novel 7,8-bridged fluoroquinolones.

38. Device Life of Two Generations of Provox Voice Prostheses.

39. Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex.

40. Sentence Recognition in Quiet and Noise by Pediatric Cochlear Implant Users: Relationships to Spoken Language.

41. Prognostic implications of and audiometric evidence for hearing fluctuation in Meniere's disease.

43. A Prospective Longitudinal Study of U.S. Children Unable to Achieve Open-Set Speech Recognition 5 Years After Cochlear Implantation.

44. An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease.

45. mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.

46. Structure of an 'open' clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport.

47. Functional determinants of gate-DNA selection and cleavage by bacterial type II topoisomerases.

48. Genetic evidence for an ethnic diversity in the susceptibility to Ménière's disease.

49. Engineering goals for future thoracic endografts-how can we make them more effective?

50. GRM7 variants associated with age-related hearing loss based on auditory perception.

Catalog

Books, media, physical & digital resources